Robert Løvsletten Smith (Robert L Smith)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 24

Top Topics

High Resolution Mass Spectrometry

Bipolar Disorder

Polycyclic Aromatic Hydrocarbons

Top Venues

Clinical and translational science

European journal of clinical pharmacology

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Robert Løvsletten Smith, Birgit M Wollmann, Elisabet Størset, Hasan Çağın Lenk, Kevin Sean O'Connell, Marianne Kristiansen Kringen, Magnus Ingelman-Sundberg, Espen Molden
Effect of the NFIB rs28379954 T>C polymorphism on CYP2D6-catalyzed metabolism of solanidine. Clinical and translational science 17 (2) (2024)
Robert Løvsletten Smith, Birgit M Wollmann, Elisabet Størset, Hasan Çağın Lenk, Kevin Sean O'Connell, Marianne Kristiansen Kringen, Magnus Ingelman-Sundberg, Espen Molden
Effect of the NFIB rs28379954 T>C polymorphism on CYP2D6-catalyzed metabolism of solanidine. Clinical and translational science 17 (2) (2024)
Hasan Çağın Lenk, Robert Løvsletten Smith, Kevin Sean O'Connell, Ole Andreas Andreassen, Espen Molden
Rapid Metabolism Underlying Subtherapeutic Serum Levels of Atypical Antipsychotics Preceding Clozapine Treatment: A Retrospective Analysis of Real-World Data. CNS drugs 38 (6) (2024)
Hasan Çağın Lenk, Robert Løvsletten Smith, Kevin Sean O'Connell, Ole Andreas Andreassen, Espen Molden
Rapid Metabolism Underlying Subtherapeutic Serum Levels of Atypical Antipsychotics Preceding Clozapine Treatment: A Retrospective Analysis of Real-World Data. CNS drugs (2024)
Hasan Çağın Lenk, Robert Løvsletten Smith, Kevin Sean O'Connell, Ole Andreas Andreassen, Espen Molden
Rapid Metabolism Underlying Subtherapeutic Serum Levels of Atypical Antipsychotics Preceding Clozapine Treatment: A Retrospective Analysis of Real-World Data. CNS drugs 38 (6) (2024)
Hasan Çağın Lenk, Robert Løvsletten Smith, Kevin Sean O'Connell, Ole Andreas Andreassen, Espen Molden
Rapid Metabolism Underlying Subtherapeutic Serum Levels of Atypical Antipsychotics Preceding Clozapine Treatment: A Retrospective Analysis of Real-World Data. CNS drugs 38 (6) (2024)
Robert Løvsletten Smith, Birgit M Wollmann, Elisabet Størset, Hasan Çağın Lenk, Kevin Sean O'Connell, Marianne Kristiansen Kringen, Magnus Ingelman-Sundberg, Espen Molden
Effect of the NFIB rs28379954 T>C polymorphism on CYP2D6-catalyzed metabolism of solanidine. Clinical and translational science 17 (2) (2024)
Robert Løvsletten Smith, Espen Molden, Jean-Paul Bernard
Effect of CYP2D6 and CYP2C19 genotypes on atomoxetine serum levels: A study based on therapeutic drug monitoring data. British journal of clinical pharmacology (2023)
Birgit M Wollmann, Elisabet Størset, Marianne Kristiansen Kringen, Espen Molden, Robert Løvsletten Smith
Prediction of CYP2D6 poor metabolizers by measurements of solanidine and metabolites-a study in 839 patients with known CYP2D6 genotype. European journal of clinical pharmacology (2023)
Vigdis Solhaug, Marit Tveito, Ragnhild Birkeland Waade, Gudrun Høiseth, Espen Molden, Robert Løvsletten Smith
Impact of age, sex and CYP genotype on quetiapine- and N-desalkylquetiapine serum concentrations - A study based on real-world data from 8118 patients. British journal of clinical pharmacology (2023)
Birgit M Wollmann, Elisabet Størset, Marianne Kristiansen Kringen, Espen Molden, Robert Løvsletten Smith
Prediction of CYP2D6 poor metabolizers by measurements of solanidine and metabolites-a study in 839 patients with known CYP2D6 genotype. European journal of clinical pharmacology 79 (4) (2023)
Birgit M Wollmann, Robert Løvsletten Smith, Marianne Kristiansen Kringen, Magnus Ingelman-Sundberg, Espen Molden, Elisabet Størset
Evidence for solanidine as a dietary CYP2D6 biomarker: Significant correlation with risperidone metabolism. British journal of clinical pharmacology (2023)
Robert Løvsletten Smith, Espen Molden, Jean-Paul Bernard
Effect of CYP2D6 and CYP2C19 genotypes on atomoxetine serum levels - a study based on therapeutic drug monitoring data. British journal of clinical pharmacology (2023)
Hasan Çağın Lenk, Robert Løvsletten Smith, Kevin Sean O'Connell, Marin M Jukić, Marianne Kristiansen Kringen, Ole Andreas Andreassen, Magnus Ingelman-Sundberg, Espen Molden
Impact of NFIB and CYP1A variants on clozapine serum concentration-A retrospective naturalistic cohort study on 526 patients with known smoking habits. Clinical and translational science (2022)
Jose De Leon, Georgios Schoretsanitis, Robert Løvsletten Smith, Espen Molden, Anssi Solismaa, Niko Seppälä, Miloslav Kopeček, Patrik Švancer, Ismael Olmos, Carina Ricciardi, Celso Iglesias-Garcia, Ana Iglesias-Alonso, Edoardo Spina, Can-Jun Ruan, Chuan-Yue Wang, Gang Wang, Yi-Lang Tang, Shih Ku Lin, Hsien-Yuan Lane, Yong Sik Kim, Se Hyun Kim, Anto P Rajkumar, Dinora Fabiola González Esquivel, Helgi Jung-Cook, Trino Baptista, Christopher Rohde, Jimmi Nielsen, Hélène Verdoux, Clelia Quiles, Emílio J Sanz, Carlos de Las Cuevas, Dan Cohen, Peter F J Schulte, Aygün Ertuğrul, Elif Anıl Yağcıoğlu, Nitin Chopra, Betsy McCollum, Charles Shelton, Robert O Cotes, Arun R Kaithi, John M Kane, Saeed Farooq, Chee H Ng, John Bilbily, Christoph Hiemke, Carlos López-Jaramillo, Ian R McGrane, Fernando Lana, Chin Bin Eap, Manuel Arrojo-Romero, Flavian Ş Rădulescu, Erich Seifritz, Susanna Every-Palmer, Chad A Bousman, Emmanuel Bebawi, Rahul Bhattacharya, Deanna L Kelly, Yuji Otsuka, Judit Lazary, Rafael Torres, Agustin Yecora, Mariano Motuca, Kit Wa Sherry Chan, Monica Zolezzi, Sami Ouanes, Domenico de Berardis, Sandeep Grover, Ric M Procyshyn, Richard A Adebayo, Oleg O Kirilochev, Andrey Soloviev, Konstantinos N Fountoulakis, Alina Wilkowska, Wiesław Jerzy Cubała, Muhammad Ayub, Alzira Silva, Raphael M Bonelli, Jose M Villagrán-Moreno, Jacqueline Mayoral-van Son, Henk S Temmingh, Eric H Decloedt, Maria R Pedro, Hiroyoshi Takeuchi, Masaru Tsukahara, Gerhard Gründer, Marina Šagud, Andreja Celofiga, Dragana Ignjatovic Ristic, Bruno B Ortiz, Helio Elkis, Antônio Pacheco Palha, Adrián LLerena, Emilio Fernandez-Egea, Dan J Siskind, Abraham Weizman, Rim Masmoudi, Shamin Mohd Saffian, Jonathan G Leung, Peter F Buckley, Stephen R Marder, Citrome Leslie, Oliver Freudenreich, Christoph U Correll, Daniel J Mueller
Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. Pharmacopsychiatry 55 (2) (2022)
Hasan Çağın Lenk, Katharina Klöditz, Inger Johansson, Robert Løvsletten Smith, Marin M Jukić, Espen Molden, Magnus Ingelman-Sundberg
The Polymorphic Nuclear Factor NFIB Regulates Hepatic CYP2D6 Expression and Influences Risperidone Metabolism in Psychiatric Patients. Clinical pharmacology and therapeutics 111 (5) (2022)
Marit Tveito, Gudrun Høiseth, Tore Haslemo, Espen Molden, Robert Løvsletten Smith
Impact of age and gender on paliperidone exposure in patients after administration of long-acting injectable formulations-an observational study using blood samples from 1223 patients. European journal of clinical pharmacology 77 (8) (2021)
Lennart Kyllesø, Robert Løvsletten Smith, Øystein Karlstad, Ole Andreas Andreassen, Espen Molden
Absolute and Dose-Adjusted Serum Concentrations of Clozapine in Patients Switching vs. Maintaining Treatment: An Observational Study of 1979 Patients. CNS drugs 35 (9) (2021)
Trine Frederiksen, Robert Løvsletten Smith, Birgit M Wollmann, Johan Areberg, Espen Molden
Validation of a Population Pharmacokinetic Model of Vortioxetine Using Therapeutic Drug Monitoring Data. Clinical pharmacokinetics 60 (11) (2021)
Jose De Leon, Georgios Schoretsanitis, Robert Løvsletten Smith, Espen Molden, Anssi Solismaa, Niko Seppälä, Miloslav Kopeček, Patrik Švancer, Ismael Olmos, Carina Ricciardi, Celso Iglesias-Garcia, Ana Iglesias-Alonso, Edoardo Spina, Can-Jun Ruan, Chuan-Yue Wang, Gang Wang, Yi-Lang Tang, Shih Ku Lin, Hsien-Yuan Lane, Yong Sik Kim, Se Hyun Kim, Anto P Rajkumar, Dinora Fabiola González Esquivel, Helgi Jung-Cook, Trino Baptista, Christopher Rohde, Jimmi Nielsen, Hélène Verdoux, Clelia Quiles, Emílio J Sanz, Carlos de Las Cuevas, Dan Cohen, Peter F J Schulte, Aygün Ertuğrul, Elif Anıl Yağcıoğlu, Nitin Chopra, Betsy McCollum, Charles Shelton, Robert O Cotes, Arun R Kaithi, John M Kane, Saeed Farooq, Chee H Ng, John Bilbily, Christoph Hiemke, Carlos López-Jaramillo, Ian R McGrane, Fernando Lana, Chin Bin Eap, Manuel Arrojo-Romero, Flavian Ş Rădulescu, Erich Seifritz, Susanna Every-Palmer, Chad A Bousman, Emmanuel Bebawi, Rahul Bhattacharya, Deanna L Kelly, Yuji Otsuka, Judit Lazary, Rafael Torres, Agustin Yecora, Mariano Motuca, Kit Wa Sherry Chan, Monica Zolezzi, Sami Ouanes, Domenico de Berardis, Sandeep Grover, Ric M Procyshyn, Richard A Adebayo, Oleg O Kirilochev, Andrey Soloviev, Konstantinos N Fountoulakis, Alina Wilkowska, Wiesław Jerzy Cubała, Muhammad Ayub, Alzira Silva, Raphael M Bonelli, Jose M Villagrán-Moreno, Jacqueline Mayoral-van Son, Henk S Temmingh, Eric H Decloedt, Maria R Pedro, Hiroyoshi Takeuchi, Masaru Tsukahara, Gerhard Gründer, Marina Šagud, Andreja Celofiga, Dragana Ignjatovic Ristic, Bruno B Ortiz, Helio Elkis, Antônio Pacheco Palha, Adrián LLerena, Emilio Fernandez-Egea, Dan J Siskind, Abraham Weizman, Rim Masmoudi, Shamin Mohd Saffian, Jonathan G Leung, Peter F Buckley, Stephen R Marder, Citrome Leslie, Oliver Freudenreich, Christoph U Correll, Daniel J Mueller
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. Pharmacopsychiatry 55 (2) (2021)
Marit Tveito, Robert Løvsletten Smith, Espen Molden, Gudrun Høiseth
Impact of age and CYP2D6 genotype on exposure of zuclopenthixol in patients using long-acting injectable versus oral formulation-an observational study including 2044 patients. European journal of clinical pharmacology 77 (2) (2020)
Robert Løvsletten Smith, Kevin Sean O'Connell, Lavinia Athanasiu, Srdjan Djurovic, Marianne Kristiansen Kringen, Ole A Andreassen, Espen Molden
Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients-a genome-wide association study adjusting for smoking habits. Translational psychiatry 10 (1) (2020)
Robert Løvsletten Smith, Kevin Sean O'Connell, Lavinia Athanasiu, Srdjan Djurovic, Marianne Kristiansen Kringen, Ole A Andreassen, Espen Molden
Correction: Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients-a genome-wide association study adjusting for smoking habits. Translational psychiatry 10 (1) (2020)
Lennart Kyllesø, Robert Løvsletten Smith, Øystein Karlstad, Ole A Andreassen, Espen Molden
Undetectable or subtherapeutic serum levels of antipsychotic drugs preceding switch to clozapine. NPJ schizophrenia 6 (1) (2020)